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Summary In June 2008 the first non-imported fatal case of Crimean-Congo hemorrhagic fever
(CCHF) was recorded in northern Greece. We present herein the public health interventions and
the case definitions we developed for the epidemiological investigation. The possibility of CCHF
establishing endemicity in this area is discussed.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.The event
In June 2008 the Hellenic Center for Disease Control and
Prevention (HCDCP; Athens, Greece) was notified about a case
of Crimean-Congo hemorrhagic fever (CCHF) that had
occurred in the Prefecture of Rhodopi, northern Greece.
The case concerned a 46-year-old woman, who was engaged
in agricultural activities and had a history of tick bite 1 day* Corresponding author. Tel.: +30 210 8899 044;
fax: +30 210 8899 330.
E-mail address: helen-maltezou@ath.forthnet.gr
(H.C. Maltezou).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.11.011before the onset of symptoms. No travel abroad or contact
with livestock, other animals, or an ill person was reported.
The patient presentedwith fever in associationwith headache
and nausea, however during the course of her disease she
developed hematomas at injection sites, a diffuse petechial
rash, and genital hemorrhage; she died 7 days following the
onset of symptoms. The following results were found on
laboratory investigation: white blood cell count, 5.62  109
cells/l (81.4% neutrophils and 15.5% lymphocytes); platelets,
100  109 cells/l; hemoglobin, 11.5 g/dl; hematocrit, 33.5%;
glutamic oxaloacetic transaminase (SGOT), 3962U/l; glutamic
pyruvic transaminase (SGPT), 1545 U/l; lactate dehydrogen-
ase, 8085 U/l. Coagulation parameters were: activated partial
thromboplastin time (aPTT): 82.6 s; international normalizedPublished by Elsevier Ltd. All rights reserved.
714 H.C. Maltezou et al.ratio (INR): 1.75; D-dimers: >10 000. The patient was tested
for hantavirus, which causes hemorrhagic fever with renal
syndrome (HFRS), leptospirosis, and rickettsial diseases; all
resultswere negative. The diagnosis of CCHFwas confirmedby
reverse transcriptase-nested PCR and quantitative real time
PCR at the World Health Organization (WHO) Collaborative
Centre for Research and Reference on Arboviruses and Hemor-
rhagic Fever Viruses (Aristotle University of Thessaloniki,
Greece). Sequencing analysis revealed that the causative
strain was phylogenetically similar to the CCHF strains circu-
lating in the Balkan countries north of Greece (Albania,
Kosovo-Yugoslavia, Bulgaria), Turkey, and Southwest Russia.1
Since then 15 additional, sporadic cases have tested negative
for CCHF; all had a history of tick bite and fever. None of the
contacts of the patient (family members or healthcare work-
ers) developed any symptom. This is the first CCHF case in
Greece.
Interventions
An ad hoc committee was established for the development of
case definitions for CCHF notification and contact tracingTable 1 Case definitions for notification of Crimean-Congo hemo
Suspect case
A patient with abrupt onset of high fever >38.5 8C, and one of
vomiting, and/or diarrhea
AND
History of tick bite within 14 days prior to the onset of symptom
History of contact with tissues, blood, or other biological fluids fr
owners, veterinarians) within 14 days prior the onset of symp
Healthcare workers in healthcare facilities, with a history of expo
within 14 days prior to the onset of symptoms
AND
The contact/exposure took place in the Prefecture of Rhodopi
Probable case
A probable CCHF case is defined as a suspected CCHF case fulfi
Thrombocytopenia
AND
Two of the following hemorrhagic manifestations: hematoma at
hematemesis, hemoptysis, gastrointestinal hemorrhage, gingiv
absence of any known precipitating factor for hemorrhagic m
Confirmed case
A confirmed CCHF case is defined as a case that fulfills the criter
the World Health Organization (WHO) Collaborating Centre for
Viruses (Aristotle University of Thessaloniki, Thessaloniki, Gre
Detection by ELISA or IFA of specific IgM antibodies against CCHF v
virus in two specimens collected in the acute and convalesce
Detection by RT-PCR of CCHF virus genome in a clinical specime
CCHF virus isolation
Contact tracing
History of contact with tissue, blood, or other biological fluids
Members of the patient’s family
Healthcare workers with a history of exposure to a suspect, pro
The abovementioned categories should be followed for the onset of
a total of 14 days following the last contact.
ELISA, enzyme-linked immunosorbent assay; IFA, indirect immunofluo
reaction.(Table 1). Written guidelines for strict isolation and prompt
management of CCHF cases within healthcare facilities were
sent to hospitals in northern Greece (Table 2). Guidelines for
appropriate disinfection of inanimate medical equipment,
cleaning procedures, management of waste, handling and
transportation of clinical specimens, management of acci-
dental needle stick injuries and contact with blood or other
potentially contaminated biological fluids, and management
of dead bodies with suspect, probable, or confirmed CCHF
were also sent to the hospitals. Information regarding pre-
vention of tick bites and proper removal of attached ticks was
disseminated to residents of and visitors to the Prefecture of
Rhodopi. At the same time the event received considerable
attention from the mass media leading to a surge in ‘tick-
phobia’. In response to this, the HCDCP informed the general
population about CCHF, the associated risk for Greece, and
preventive measures for tick bites.
In order to complete a risk assessment for CCHF in Greece,
the following actions have been scheduled by the HCDCP and
the ministries of health and agricultural development: (1)
serosurveys in indigenous populations of all ages in northern
Greece; (2) serosurveys in livestock animals throughout the
northern border areas of Greece; and (3) testing ticks col-rrhagic fever (July 2008)
the following symptoms: severe headache, myalgias, nausea,
s; or
om a possibly infected animal (e.g., abattoir workers, livestock
toms; or
sure to a suspect, probable, or laboratory-confirmed CCHF case,
lling in addition the following criteria:
an injection site, petechiae, purpuric rash, rhinorrhagia,
al hemorrhage, or any other hemorrhagic manifestation in the
anifestation
ia for probable CCHF and in addition is laboratory-confirmed at
Reference and Research on Arboviruses and Hemorrhagic Fever
ece) with one of the following assays:
irus or a 4-fold increase in specific IgG antibodies against CCHF
nce phases
n confirmed by sequencing of the PCR product
from the same possibly infected animal
bable, or laboratory-confirmed CCHF case
symptoms or fever (measurement of temperature every day) for
rescence assay; RT-PCR, reverse transcriptase polymerase chain
Table 2 Guidelines for the prevention of transmission of CCHF within a healthcare facility and the prompt management of CCHF
cases
Immediately isolate all suspect, probable, or confirmed CCHF cases under strict contact precautions
Use of personal protective equipment by all HCWs entering the isolation room
Notify all suspect, probable, or confirmed CCHF cases to the HCDCP
Inform the hospital Committee for Nosocomial Infections about the suspect, probable, or confirmed CCHF case
Educate HCWs about appropriate infection control measures
Send clinical specimens for laboratory diagnosis to the WHO Collaborating Centre for Reference and Research on Arboviruses and
Hemorrhagic Fever Viruses (Aristotle University of Thessaloniki, Greece)
Consider administering ribavirin (in accordance with WHO recommendations). Ribavirin should be introduced within 3—4 days from
the onset of symptoms and while awaiting laboratory results
CCHF, Crimean-Congo hemorrhagic fever; HCWs, healthcare workers; HCDCP: Hellenic Center for Disease Control and Prevention.
Crimean-Congo hemorrhagic fever in Greece 715lected from domestic animals from northern Greece. Collec-
tion and testing of serum specimens from healthcare workers
with a history of contact with the case is underway.
Discussion
CCHF is an acute, highly contagious, tick-borne viral zoonosis.
Hemorrhagic manifestations develop in late-stage disease,
and published mortality rates range from 10% to 50%. Of all
tick-borne viruses, CCHF virus has the greatest geographic
distribution, being endemic in more than 30 countries in
Africa, central and southwestern Asia, the Middle East, and
Eastern Europe.2 Numerous domestic and wild animals may
serve as hosts, including cattle, sheep, goats, horses, pigs,
hares, ostriches, camels, donkeys, hedgehogs, mice, and
domestic dogs.2 Infection is transmitted to humans through
the bite of ticks (mainly of the genus Hyalomma) or through
unprotected contact with blood or tissues from infected ani-
mals or humans.2—5 Nosocomial transmission is a major mode
of acquisition of infection.2 CCHF fulfills the criteria for
immediate notification because of its high mortality, the
potential for human-to-human transmission, the need for
strict implementation of infectioncontrolmeasures, the avail-
ability of treatment with ribavirin, the potential of misdiag-
nosis of imported cases, and thepotential useas a bioterrorism
agent.2 Hemorrhagic fevers are included in the list of diseases,
along with pneumonic plague and yellow fever, for which the
Revised International Health Regulations call for implementa-
tion of the decision algorithm to determine whether notifica-
tion to the WHO is indicated.6
Over the last decade, climate, environmental, and anthro-
pogenic factors have driven the expansion of CCHF endemic
foci and the onset of community outbreaks. Such outbreaks
were recorded in Kosovo in 2001 and Turkey in 2003—2008,
countries neighboring Greece.2,3,7,8 In April 2008, a cluster of
probable CCHF cases occurred in southern Bulgaria, a few
kilometers from the border with Greece.9 Turkey and Balkan
countries with the exception of Greece have recorded circula-
tion of CCHF strains among animal hosts, ticks, and humans,
and have established CCHF endemicity.5 The wide outbreaks
that occurred in Turkey were preceded by several decades of
serologic evidence of a zoonotic CCHF focus.2
Available data indicate limited, if any, circulation of CCHF
virus in Greece. In 1976 an asymptomatic, laboratory-
acquired CCHF infection occurred in a veterinarian in Greece
who was working with the AP-92 strain. The AP-92 CCHF virusstrain was isolated from Rhipicephalus bursa ticks collected
from goats in northern Greece, and differs from all other
CCHF virus strains.2,10 In a study conducted during 1980—
1981 among 65 adults from villages in northern Greece,
evidence of previous CCHF infection was found in four
(6%), however none of them recalled any serious illness
resembling CCHF.11 Antoniadis et al. tested 3388 apparently
healthy farmers, woodcutters, and shepherds from all over
Greece from 1981 to 1988, of whom 1% had antibodies against
CCHF virus.12 Given the paucity of clinical CCHF cases in
Greece during the last three decades, it appears that this
seroprevalence reflects previous possible infection with the
AP-92 strain and not with the pathogenic Balkan CCHF strain.
Starting from 1982, Greek patients with a disease compatible
with hemorrhagic fever have been tested and found negative
for CCHF.
The establishment and maintenance of a CCHF endemic
focus requires an environment favoring an efficient contact
between competent ticks and animal hosts with relatively
high prevalence of infection. Heterogeneity in infection
levels may occur even within endemic foci, as a result of
variable climate and environmental suitability for ticks and
animal hosts.3 To date, domestic animal serological data from
northern Greece indicate no previous exposure to CCHF and
thus it is highly unlikely that these animals could potentially
serve as hosts (Greek Ministry of Agricultural Development,
personal communication). This information needs to be
further confirmed in future studies. However, recent studies
reveal that Hyalomma ticks are abundant in northern
Greece,13,14 a finding that could be partially attributed to
the increased (by approximately 2 8C) mean temperatures
and mean maximum temperatures in this area during the last
25 years (Greek National Metereologic Services; personal
communication). Pavlidou et al. found that of a total of
3249 ticks collected from domestic animals near oak and
coniferous forests in 11 prefectures of northern Greece
during 2003—2006, Hyalomma marginatum ticks accounted
for 12.4% of all ticks, third to Ixodes ricinus and R. bursa ticks
(44.57% and 19.15%, respectively).14 In this study, H. margin-
atum ticks were found in all investigated prefectures. One
could not exclude the possibility of CCHF becoming endemic
in that area under conditions favoring suitable infection
levels among animal hosts. Nevertheless, it appears that
the current CCHF case was an isolated event, and transmis-
sion was achieved through a tick bite. CCHF should be
considered in a patient with a history of tick bite and a
compatible clinical syndrome in areas neighboring those with
716 H.C. Maltezou et al.established endemicity. In the Balkans, CCHF should be
considered alongwith hantavirus HFRS, rickettsial infections,
and leptospirosis — infections with similar clinical manifesta-
tions.
Case definitions constitute the basis for epidemiological
surveillance and their performance may influence not only
the accurate estimation of the spread of a disease, but also
could compromise prompt responses and interventions at the
patient, community, and hospital level. The development of
case definitions for CCHF was a challenge for us, given the
lack of experience on non-imported CCHF cases in other
developed countries. Their application is not intended for
diagnostic or therapeutic decisions, but targets the early and
accurate detection of a CCHF case and its contacts, in order
to trigger response measures for disease containment. The
threshold of thrombocytopenia (150  109 platelets/l)15 and
the extension of the geographic area under epidemiological
surveillance were thoroughly discussed. We aimed at the
development of case definitions of suspect cases that had
a good balance between an increased sensitivity (trying to
catch early cases rapidly) and a lower specificity. This was
important in order to react to the crisis and at the same time
avoid overuse of resources, in a country with no circulation of
CCHF virus to date. For this reason, an expansion of the area
under surveillance to include a total of six prefectures in the
regions of Thrace and Eastern Macedonia, instead of limiting
surveillance to the Prefecture of Rhodopi where the first
CCHF case occurred, was discussed. This discussion was based
on the abundance of Hyalomma ticks in these areas in north-
ern Greece.14 In order to ensure the efficacy of our approach,
case definitions should be tested in real practice and in a
large number of cases, which was not the case here. Our case
definitions have been forwarded to the European Center for
Disease Control and will be considered for the development
of uniform case definitions for non-imported CCHF cases
within the European Union.
Over recent decades, alterations in natural ecosystems,
intensive agriculture, global warming, and the exponential
increase of movement of people for any cause have provided
the framework for the expansion of several vector-borne
diseases globally, from endemic areas to neighboring non-
endemic areas as well as to distant continents.7,16—20 The
spread of West Nile virus from Africa to the east coast of the
USA, followed by the expansion of this infection across this
country within less than a decade, constitutes the most
striking paradigm.16 Global warming may also have influ-
enced CCHF prevalence in already endemic areas by altering
the ticks’ growth pattern, but also in areas currently free of
CCHF, by redirecting the migration routes of birds that host
the affected ticks to areas newly warmed by the earth’s
altered temperature patterns.7 Whether this will be the case
for CCHF in Greece or for other vector-borne diseases in
Europe and other developed countries with temperate cli-
mates in coming years is unknown. In the meantime, the
public health sector, especially in Greece, which is at the
crossroads between Africa, Europe, and Asia, has to be
prepared for the worst-case scenario.
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